---
figid: PMC7547737__41598_2020_73835_Fig7_HTML
figlink: pmc/articles/PMC7547737/figure/Fig7/
number: F7
caption: Proposed ERBB2 intracellular mechanism of action. (a,b) Abs treatment induces
  ERBB2 homodimerization and transactivation of Tyr1248. (b,c) ERBB2 C-terminal domain
  phosphorylation induces MAPK (ERK) pathway activation. (c,d) Active ERK binds to
  and phosphorylates ERBB2 Thr701 residue, sustaining ERBB2 C-terminal domain phosphorylation
  (positive feedback loop), and fostering the recruitment of phospho-AKT and CyPA
  onto the receptor. (d,e) CyPA binding to ERBB2 Pro702 residue possibly sequesters
  the immunophilin from the interaction with phospho-AKT, which becomes accessible
  to and is de-phosphorylated by PP2A Ser/Thr phosphatase.
pmcid: PMC7547737
papertitle: Direct stimulation of ERBB2 highlights a novel cytostatic signaling pathway
  driven by the receptor Thr701 phosphorylation.
reftext: Marco Gaviraghi, et al. Sci Rep. 2020;10:16906.
pmc_ranked_result_index: '52811'
pathway_score: 0.5052574
filename: 41598_2020_73835_Fig7_HTML.jpg
figtitle: Proposed ERBB2 intracellular mechanism of action
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7547737__41598_2020_73835_Fig7_HTML.html
  '@type': Dataset
  description: Proposed ERBB2 intracellular mechanism of action. (a,b) Abs treatment
    induces ERBB2 homodimerization and transactivation of Tyr1248. (b,c) ERBB2 C-terminal
    domain phosphorylation induces MAPK (ERK) pathway activation. (c,d) Active ERK
    binds to and phosphorylates ERBB2 Thr701 residue, sustaining ERBB2 C-terminal
    domain phosphorylation (positive feedback loop), and fostering the recruitment
    of phospho-AKT and CyPA onto the receptor. (d,e) CyPA binding to ERBB2 Pro702
    residue possibly sequesters the immunophilin from the interaction with phospho-AKT,
    which becomes accessible to and is de-phosphorylated by PP2A Ser/Thr phosphatase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DDX41
  - ERBB2
  - MAPK3
  - MAPK1
  - AKT2
  - AKT3
  - AKT1
  - MTSS1
  - Te
  - Lapatinib
  - Okadaic Acid
  - Tautomycin
genes:
- word: Abs
  symbol: ABS
  source: hgnc_alias_symbol
  hgnc_symbol: DDX41
  entrez: '51428'
- word: Abs
  symbol: ABS
  source: hgnc_alias_symbol
  hgnc_symbol: DDX41
  entrez: '51428'
- word: ERBB2
  symbol: ERBB2
  source: hgnc_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Abs
  symbol: ABS
  source: hgnc_alias_symbol
  hgnc_symbol: DDX41
  entrez: '51428'
- word: MIM
  symbol: MIM
  source: hgnc_alias_symbol
  hgnc_symbol: MTSS1
  entrez: '9788'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
chemicals:
- word: Te
  source: MESH
  identifier: D013691
- word: Lapatinib
  source: MESH
  identifier: C490728
- word: Okadaic Acid
  source: MESH
  identifier: D019319
- word: Tautomycin
  source: MESH
  identifier: C053079
diseases: []
figid_alias: PMC7547737__F7
redirect_from: /figures/PMC7547737__F7
figtype: Figure
---
